This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • World Health  • War  • Malaria  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Following the September 11, 2001, attacks on New York and Washington, the International Security Assistance Force (ISAF) was created in Afghanistan in December 2001 with support from 16 nations. By 2006, ISAF support increased to 36 nations, with approximately 115 000 coalition troops serving during this period. Malaria, especially Plasmodium vivax, is prevalent between May and November in all areas of Afghanistan less than 6667 feet above sea level.¹ Since 2002, 85 cases of P vivax malaria have been reported in British, German, and US troops that have been linked to military service with ISAF,^2-4 and it is likely that additional cases have occurred.

We conducted a survey to compare malaria prevention measures in use by coalition forces in Afghanistan in 2006 and to evaluate the level of international agreement for this area of clinical practice.

Methods

In June 2006 the malaria prevention policy of each ISAF force . . . [Full Text of this Article]

Ashley M. Croft, MD
ashley.croft810@land.mod.uk
Headquarters Fifth Division
Shrewsbury, United Kingdom

Alicia H. Darbyshire, MD
Headquarters International Security Assistance Force
Kabul, Afghanistan

Christopher J. Jackson, MD
Camp Souter
Kabul, Afghanistan

Pieter P. van Thiel, MD
Academic Medical Center
University of Amsterdam
Amsterdam, the Netherlands

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Malaria Chemoprophylaxis for Coalition Troops in Afghanistan
Tepper et al.
JAMA 2007;298:1275-1275.
FULL TEXT